CN116102666A - 2-quaternary ammonium salt modified ethyl cellulose derivative and preparation method and application thereof - Google Patents

2-quaternary ammonium salt modified ethyl cellulose derivative and preparation method and application thereof Download PDF

Info

Publication number
CN116102666A
CN116102666A CN202310124017.7A CN202310124017A CN116102666A CN 116102666 A CN116102666 A CN 116102666A CN 202310124017 A CN202310124017 A CN 202310124017A CN 116102666 A CN116102666 A CN 116102666A
Authority
CN
China
Prior art keywords
quaternary ammonium
ammonium salt
compound
salt modified
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202310124017.7A
Other languages
Chinese (zh)
Inventor
付伯桥
邹晶
毛重阳
覃彩芹
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hubei Engineering University
Original Assignee
Hubei Engineering University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hubei Engineering University filed Critical Hubei Engineering University
Priority to CN202310124017.7A priority Critical patent/CN116102666A/en
Publication of CN116102666A publication Critical patent/CN116102666A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B11/00Preparation of cellulose ethers
    • C08B11/20Post-etherification treatments of chemical or physical type, e.g. mixed etherification in two steps, including purification
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/02Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms
    • A01N43/04Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom
    • A01N43/14Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom six-membered rings
    • A01N43/16Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom six-membered rings with oxygen as the ring hetero atom
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/34Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
    • A01N43/40Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/48Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
    • A01N43/501,3-Diazoles; Hydrogenated 1,3-diazoles
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01PBIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
    • A01P1/00Disinfectants; Antimicrobial compounds or mixtures thereof
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

The invention relates to a 2-quaternary ammonium salt modified ethyl cellulose derivative, and a preparation method and application thereof. The invention synthesizes cellulose containing bromoacetate structure by adopting the reaction of high activity acyl bromide reagent and 2-hydroxyl of ethyl cellulose under alkaline condition, and then builds quaternary ammonium salt by utilizing nucleophilicity of nitrogen-containing compound. The ethyl cellulose derivative modified by the quaternary ammonium salt has good escherichia coli inhibition activity after being subjected to enzymatic degradation, and has the advantages of high yield and simple operation.

Description

2-quaternary ammonium salt modified ethyl cellulose derivative and preparation method and application thereof
Technical Field
The invention relates to the technical field of antibacterial materials, in particular to a 2-quaternary ammonium salt modified ethylcellulose derivative, a preparation method and application thereof.
Background
Antibacterial materials are widely used in natural environments and daily life of human beings, and are functional materials with sterilizing or bacteriostasis capability. Antibacterial materials can be classified into inorganic and organic antibacterial materials, and can be classified into natural antibacterial materials and synthetic antibacterial materials from the viewpoint of artificial synthesis. At present, the research and development of novel antibacterial materials with environmental protection, durability, broad spectrum and high efficiency are uniformly accepted by all communities, and become a popular research direction of the industry.
Cellulose is natural polysaccharide formed by polymers from glucose, and has the advantages of environmental protection, being degradable by enzymes and the like. Glucose has better water solubility when the polymerization degree is lower, has a certain antibacterial property, is used as a good nutrient substance at the same time, and is beneficial to the growth of bacteria at a higher concentration. The ethylcellulose has certain fat solubility, overcomes the defect of insufficient fat solubility when the polymerization degree of glucose is low, has the advantage of being degraded by enzyme, and is more beneficial to penetrating through cell walls after being degraded by enzyme. Based on the advantages, the ethyl cellulose is widely used as a bacteriostatic raw material at present, but the ethyl cellulose is mostly used as a matrix or film forming material, and the bacteriostatic effect of the ethyl cellulose is further improved by not directly carrying out chemical modification on the ethyl cellulose. The application document with publication number of CN11358178A discloses an alkyl glycoside biological bacteriostat and a preparation process thereof, wherein ethyl cellulose is used as a film forming material to be matched with a bacteriostasis component and other auxiliary agents to be a bacteriostat, and water is required to be added for swelling when the ethyl cellulose is used, so that the preparation process is complex.
Disclosure of Invention
The invention provides a 2-quaternary ammonium salt modified ethyl cellulose derivative, a preparation method and application thereof, wherein a high-activity acyl bromide reagent is adopted to react with 2-hydroxyl of ethyl cellulose to construct cellulose containing bromoacetate structure under alkaline condition, and then nucleophilic property of a nitrogen-containing compound is utilized to construct quaternary ammonium salt. The ethyl cellulose derivative modified by the quaternary ammonium salt has good escherichia coli inhibition activity after being subjected to enzymatic degradation, and has the advantages of high yield and simple operation.
The scheme for solving the technical problems is as follows: a2-quaternary ammonium salt modified ethyl cellulose derivative has a structural formula as follows:
Figure BDA0004081109060000021
wherein r=n + (CH 3 ) 3 Br - ,N + (CH 2 CH 3 ) 3 Br - ,
Figure BDA0004081109060000022
n=40-50. The synthetic route of the above 2-quaternary ammonium salt modified ethylcellulose derivative is as follows: />
Figure BDA0004081109060000023
Wherein r=n + (CH 3 ) 3 Br - ,N + (CH 2 CH 3 ) 3 Br - ,
Figure BDA0004081109060000024
n=40-50;
The synthesis steps are as follows:
a) Compound 1 is dissolved in a first solvent, organic base is added, stirring is carried out for 4-6 hours at room temperature, and cooling is carried out to 0-5 ℃. Bromoacetyl bromide is added dropwise, the reaction is carried out for half an hour at 0-5 ℃, the temperature is restored to room temperature, the mixture obtained after stirring for 24-36 hours is poured into a large amount of cold water, white solid is separated out, the white solid is filtered, and the compound 3 is obtained after the solid is dried.
b) Dissolving the compound 3 in a second solvent, adding a nitrogen-containing compound at room temperature, stirring for 24-36 hours at 25-100 ℃, cooling to room temperature, pouring the obtained mixture into cold water, precipitating a pale yellow solid, filtering, and drying to obtain the compound I.
Preferably, the molar ratio of compound 1 to bromoacetyl bromide in step a) is 1:1.2-1.5. Preferably, in the step a), the first solvent is one or a mixture of a plurality of anhydrous tetrahydrofuran and dichloromethane.
Preferably, in the step a), the organic base is one of triethylamine and pyridine.
The process for the preparation of a 2-quaternary ammonium salt modified ethylcellulose derivative as claimed in claim 2 wherein said step b) is carried out in a molar ratio of compound 3 to nitrogen-containing compound of from 1:1.1 to 1.5.
Preferably, in the step b), the second solvent is one or a mixture of a plurality of anhydrous tetrahydrofuran and dichloromethane.
Preferably, the nitrogen-containing compound in the step b) is one of trimethylamine, triethylamine, 1-methylimidazole and pyridine.
The application of the ethyl cellulose derivative modified by the 2-quaternary ammonium salt in antibacterial materials is disclosed.
Preferably, the antibacterial material has a bacteriostasis rate of 40-81%, more preferably 80-81% to Escherichia coli.
The beneficial effects of the invention are as follows: the invention adopts the acyl bromide reagent with high activity to react with the 2-hydroxyl of the ethyl cellulose to construct cellulose containing bromoacetate structure under alkaline condition, and then utilizes the nucleophilicity of the nitrogen-containing compound to construct quaternary ammonium salt modified ethyl cellulose. The reaction operation is simple, the reaction condition is mild, and the yield is high; the prepared ethyl cellulose derivative modified by the 2-quaternary ammonium salt has good escherichia coli resistance after being degraded by cellulase.
The foregoing description is only an overview of the present invention, and is intended to provide a better understanding of the present invention, as it is embodied in the following description, with reference to the preferred embodiments of the present invention and the accompanying drawings. Specific embodiments of the present invention are given in detail by the following examples and the accompanying drawings.
Drawings
The accompanying drawings, which are included to provide a further understanding of the invention and are incorporated in and constitute a part of this application, illustrate embodiments of the invention and together with the description serve to explain the invention and do not constitute a limitation on the invention. In the drawings:
FIG. 1 is a structural formula diagram of a 2-quaternary ammonium salt modified ethylcellulose derivative provided by the invention;
fig. 2 is a synthetic circuit diagram of the 2-quaternary ammonium salt modified ethylcellulose derivative provided by the invention.
Detailed Description
The principles and features of the present invention are described below with reference to the drawings, the examples are illustrated for the purpose of illustrating the invention and are not to be construed as limiting the scope of the invention.
Example 1
The synthetic scheme for compound I-1 is shown below:
Figure BDA0004081109060000041
the synthesis steps are as follows:
a) Preparation of compound 3 (2-bromoacetate-ethylcellulose): 10g of Compound 1 (ethylcellulose) was dispersed in 120mL of anhydrous tetrahydrofuran, and 8.63mL of pyridine was added to the reaction solution under ice-water bath conditions. 7.42mL of bromoacetyl bromide was dissolved in 10mL of tetrahydrofuran and slowly added dropwise to the reaction system. The reaction system was poured into a large amount of water, and a white solid was precipitated, filtered, and dried to give compound 3 (12.0696 g, yield: 79.6%).
b) Preparation of compound I-1 (2- (1-N, N, N-trimethylacetate) -ethylcellulose): compound 3 (3.552 g,10 mmol) was weighed out, anhydrous tetrahydrofuran was added under nitrogen protection, and the mixture was stirred and dispersed at room temperature. At room temperature, 15mmol of 1M/L trimethylamine tetrahydrofuran solution is dripped into the reaction system, and stirring is continued for about 24 hours. After the reaction, the mixture was diluted with methylene chloride or diethyl ether and centrifuged. The supernatant was poured into a large amount of water to precipitate a white solid, which was filtered under reduced pressure and dried under vacuum to give solid compound I-1 (3.629 g, yield: 87.6%).
Compound I-1 was taken for characterization and the results were as follows:
FTIR characterization: 2977cm -1 ,2931cm -1 ,2861cm -1 (saturated CH), 1747cm -1 (C=O),1261cm -1 (C-N),1081cm -1 (C-O-C),1049cm -1 (C-O-C on sugar ring).
1H NMR(400MHz,CDCl 3 )δ5.09-2.71(O-CH 2 and N-CH 3 ,22H),1.17(CH 3 ,CH 3 CH 2 ,9H).
Example 2
The synthetic scheme for compound I-2 is shown below:
Figure BDA0004081109060000051
the synthesis steps are as follows:
a) Preparation of compound 3 (2-bromoacetate-ethylcellulose): the specific operation is the same as in step a) in example 1.
b) Preparation of Compound I-2 (2- (1-N, N, N-triethylacetate) -ethylcellulose): compound 3 (3.552 g,10 mmol) was weighed out, anhydrous tetrahydrofuran was added under nitrogen protection, and the mixture was stirred and dispersed at room temperature. At room temperature, 15mmol of 1M/L triethylamine tetrahydrofuran solution was added dropwise to the reaction system, and stirring was continued for about 24 hours. After the reaction, the mixture was diluted with methylene chloride or diethyl ether and centrifuged. The supernatant was poured into a large amount of water to precipitate a white solid, which was filtered under reduced pressure and dried under vacuum to give solid compound I-2 (3.017 g, yield: 66.1%).
Compound I-2 was taken for characterization and the results were as follows:
FTIR characterization: 2972cm -1 ,2917cm -1 ,2875cm -1 (saturated CH), 1747cm -1 (C=O),1278cm -1 (C-N),1081cm -1 (C-O-C),1049cm -1 (C-O-C on sugar ring).
1 H NMR(400MHz,CDCl 3 )δ5.08-2.97(O-CH 2 and N-CH 3 ,19H),1.16(CH 3 ,CH 3 CH 2 N and CH 3 CH 2 O,15H).
Example 3
The synthetic scheme for compound I-3 is shown below:
Figure BDA0004081109060000061
a) Preparation of compound 3 (2-bromoacetate-ethylcellulose): the specific operation is the same as in step a) in example 1.
b) Preparation of compound I-3 (2- (1-methyl-1H-imidazolium acetate) -ethylcellulose): compound 3 (3.552 g,10 mmol) was weighed out, anhydrous tetrahydrofuran was added under nitrogen protection, and the mixture was stirred and dispersed at room temperature. At room temperature, 15mmol of 1M/L1-methylimidazole in tetrahydrofuran was added dropwise to the reaction system, and the mixture was heated to 60℃and stirred for 36 hours. Cooled to room temperature, diluted with dichloromethane or diethyl ether and centrifuged. The supernatant was poured into a large amount of water to precipitate a white solid, which was filtered under reduced pressure and dried under vacuum to give solid compound I-3 (1.557 g, yield: 35.6%).
Compound I-3 was taken for characterization and the results were as follows:
FTIR characterization: 2871cm -1 ,2866cm -1 (saturated CH), 1768cm -1 (C=O),1629cm -1 (C=C),1378cm -1 (CH 3 ),1107cm -1 (C-O-C),1048cm -1 (C-O-C on sugar ring), 923cm -1 (imidazole ring C-H flexural vibration).
1 H NMR(400MHz,CDCl 3 )δ7.48(s,H,imidazole-H),7.05(s,H,imidazole-H),6.90(s,H,imidazole-H),4.79-3.03(O-CH 2 and N-CH 3 ,16H),1.27-1.14(CH 3 ,CH 3 CH 2 O,6H).
Example 4
The synthetic scheme for compound I-4 is shown below:
Figure BDA0004081109060000071
a) Preparation of compound 3 (2-bromoacetate-ethylcellulose): the specific operation is the same as in step a) in example 1.
b) Preparation of compound I-4 (2- (1-pyridinylacetate) -ethylcellulose): compound 3 (3.552 g,10 mmol) was weighed out, anhydrous tetrahydrofuran was added under nitrogen protection, and the mixture was stirred and dispersed at room temperature. 15mmol of pyridine in tetrahydrofuran was added dropwise to the reaction system at room temperature, and the mixture was stirred at 60℃for 24 hours. Cooled to room temperature, diluted with dichloromethane or diethyl ether and centrifuged. The supernatant was poured into a large amount of water to precipitate an orange-yellow solid, which was filtered under reduced pressure and dried under vacuum to give solid compound I-4 (1.212 g, yield: 34.2%).
Compound I-4 was taken for characterization and the results were as follows:
FTIR characterization: 2972cm -1 ,2863cm -1 (saturated CH) 1760cm -1 (C=O)1637cm -1 (pyridine ring c=c), 1374cm -1 (CH 3 ),1343cm -1 (C-N),1111cm -1 (primary alcohol C-O), 1054cm -1 (C-O-C on sugar ring).
1 H NMR(400MHz,CDCl 3 )δ9.36(s,H,pyridine-H),8.52(s,H,pyridine-H),8.09(s,H,pyridine-H),4.98-3.02(O-CH 2 and CH,13H),1.17-1.15(CH 3 ,CH 3 CH 2 O,6H).
Example 5 determination of bacteriostatic Activity
1) Preparation of crude solution of chitosan enzyme
30g of a powdery enzyme sample (chitosanase content: 68%) was weighed, dissolved in 70mL of distilled water, stirred and left to stand, and sufficiently soaked for 3 hours. Centrifuging with a centrifuge at 4000r/min for 20min to obtain yellow supernatant. The enzyme-containing supernatant was packaged and stored in a refrigerator at 4 ℃.
2) Enzymolysis of Compound I-1-I-4
The solid sample compounds I-1-I-4 prepared in examples 1-6 were weighed out using an analytical balance and dissolved in 1mL of a buffered solution of citric acid-disodium hydrogen phosphate at pH 4.8, respectively. The corresponding 20mmol/L concentration sample I-1-I-4 is prepared, 2mL of activated chitosanase crude solution is added, and after hydrolysis for about 100 minutes at 50 ℃, the temperature is heated to 100 ℃ to inactivate enzymes in the degradation sample I-1-I-4. Then, the sample I-1-I-4 was subjected to centrifugation (rotation speed 4000r/min, time 5-10 min). After centrifugation, the supernatant was taken, the degraded sample solution I-1-I-4 was added to the LB medium with E.coli, 1mL of a buffer solution of citric acid-disodium hydrogen phosphate having a pH of 4.8 was added to the LB medium with E.coli, the mixture was set as a blank, and the blank and the sample solution I-1-I-4 were cultured in a constant temperature incubator for 24 hours (culture temperature: 37 ℃ C.), and the antibacterial ratio was calculated, and the results were shown in Table 1.
Calculating the bacteriostasis rate: antibacterial ratio (%) = [ (sample outer diameter-sample inner diameter) - (blank outer diameter-blank inner diameter) ]/(sample outer diameter-sample inner diameter) = [ (sample outer diameter-blank outer diameter) ]/(sample outer diameter-sample inner diameter) ]×100%.
Antibacterial Activity of Compounds I-1-I-4 after enzymatic hydrolysis
Figure BDA0004081109060000081
When the substituent r=nme 3 (Compound I-1), NEt 3 (compound I-2), the chain hydrocarbon substituent is superior to the heterocyclic ring I-3 and I-4 substituent, so that the antibacterial activity is higher, and the antibacterial rate of the compound I-3 is superior to that of the compound I-4 related to the amphiphilicity of the imidazolyl.
The above description is only of the preferred embodiments of the present invention, and is not intended to limit the present invention in any way; those skilled in the art will readily appreciate that the present invention may be implemented as shown in the drawings and described above; however, those skilled in the art will appreciate that many modifications, adaptations, and variations of the present invention are possible in light of the above teachings without departing from the scope of the invention; meanwhile, any equivalent changes, modifications and evolution of the above embodiments according to the essential technology of the present invention still fall within the scope of the present invention.

Claims (10)

1. A 2-quaternary ammonium salt modified ethylcellulose derivative, which is characterized in that the structural formula is as follows:
Figure FDA0004081109040000011
wherein r=n + (CH 3 ) 3 Br - ,N + (CH 2 CH 3 ) 3 Br - ,
Figure FDA0004081109040000012
n=40-50。
2. The preparation of a 2-quaternary ammonium salt modified ethylcellulose derivative as claimed in claim 1 wherein the synthetic route is as follows:
Figure FDA0004081109040000013
wherein r=n + (CH 3 ) 3 Br - ,N + (CH 2 CH 3 ) 3 Br - ,
Figure FDA0004081109040000014
n=40-50;
The synthesis steps are as follows:
a) Dissolving the compound 1 in a first solvent, adding an organic base, stirring at room temperature, dropwise adding bromoacetyl bromide under the condition of ice bath external bath, continuously reacting, recovering to room temperature, stirring for 24-36 hours, pouring the obtained mixture into a large amount of cold water, precipitating a solid, filtering, and drying the solid to obtain a compound 3;
b) And (3) dissolving the compound 3 in a second solvent, adding a nitrogen-containing compound at room temperature, stirring for reaction for 24-36 hours, cooling to room temperature, pouring the obtained mixture into cold water, precipitating a solid, filtering, and drying to obtain the compound I.
3. The method for preparing a 2-quaternary ammonium salt modified ethylcellulose derivative as claimed in claim 2 wherein said step a) is performed in a molar ratio of 1:1.2-1.5 of compound 1 to bromoacetyl bromide.
4. The method for preparing a 2-quaternary ammonium salt modified ethylcellulose derivative as claimed in claim 2 wherein said step a) is performed by using a first solvent selected from the group consisting of anhydrous tetrahydrofuran and dichloromethane.
5. The method for preparing a 2-quaternary ammonium salt modified ethylcellulose derivative as claimed in claim 2 wherein said organic base in said step a) is one of triethylamine and pyridine.
6. The process for the preparation of a 2-quaternary ammonium salt modified ethylcellulose derivative as claimed in claim 2 wherein said step b) is carried out in a molar ratio of compound 3 to nitrogen-containing compound of from 1:1.1 to 1.5.
7. The method for preparing a 2-quaternary ammonium salt modified ethylcellulose derivative as claimed in claim 2 wherein said second solvent in said step b) is one or a mixture of two of anhydrous tetrahydrofuran and dichloromethane.
8. The method for preparing a 2-quaternary ammonium salt modified ethylcellulose derivative as claimed in claim 2, wherein said nitrogen-containing compound in said step b) is one of trimethylamine, triethylamine, 1-methylimidazole and pyridine.
9. Use of a 2-quaternary ammonium salt modified ethylcellulose derivative as claimed in claim 1 in the preparation of an antibacterial material.
10. The use of a 2-quaternary ammonium salt modified ethylcellulose derivative as claimed in claim 9 in said antimicrobial material, wherein said antimicrobial material has a bacteriostasis rate of 40-81% for escherichia coli.
CN202310124017.7A 2023-02-13 2023-02-13 2-quaternary ammonium salt modified ethyl cellulose derivative and preparation method and application thereof Pending CN116102666A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202310124017.7A CN116102666A (en) 2023-02-13 2023-02-13 2-quaternary ammonium salt modified ethyl cellulose derivative and preparation method and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202310124017.7A CN116102666A (en) 2023-02-13 2023-02-13 2-quaternary ammonium salt modified ethyl cellulose derivative and preparation method and application thereof

Publications (1)

Publication Number Publication Date
CN116102666A true CN116102666A (en) 2023-05-12

Family

ID=86267101

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202310124017.7A Pending CN116102666A (en) 2023-02-13 2023-02-13 2-quaternary ammonium salt modified ethyl cellulose derivative and preparation method and application thereof

Country Status (1)

Country Link
CN (1) CN116102666A (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4035457A (en) * 1975-05-01 1977-07-12 Chemical Systems Incorporated Nonbiodegradable polymers
KR20070078172A (en) * 2006-01-26 2007-07-31 코오롱생명과학 주식회사 Process for preparing quaternary nitrogen-containing cellulose ether
CN101812140A (en) * 2010-01-21 2010-08-25 清华大学 Cyclodextrin-bonded comb-shaped copolymer and preparation method thereof
CN113116748A (en) * 2021-04-22 2021-07-16 维尼健康(深圳)股份有限公司 Medical disinfection wet tissue capable of promoting wound healing

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4035457A (en) * 1975-05-01 1977-07-12 Chemical Systems Incorporated Nonbiodegradable polymers
KR20070078172A (en) * 2006-01-26 2007-07-31 코오롱생명과학 주식회사 Process for preparing quaternary nitrogen-containing cellulose ether
CN101812140A (en) * 2010-01-21 2010-08-25 清华大学 Cyclodextrin-bonded comb-shaped copolymer and preparation method thereof
CN113116748A (en) * 2021-04-22 2021-07-16 维尼健康(深圳)股份有限公司 Medical disinfection wet tissue capable of promoting wound healing

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
费鹏飞: ""抗菌醋酸纤维素反渗透膜的制备及性能研究"", 《中国博士学位论文全文数据库 工程科技I辑》, no. 8, 15 August 2018 (2018-08-15), pages 015 - 9 *

Similar Documents

Publication Publication Date Title
EP0291130A2 (en) Biosensor with enzymatic membrane chemically bound to a semiconductor device
CN101696213A (en) Synthetic method of 7-MAC intermediate
CN116102666A (en) 2-quaternary ammonium salt modified ethyl cellulose derivative and preparation method and application thereof
EP0046186B1 (en) Method of preparing d-n-carbamoyl-alpha-amino acids, and microorganisms therefor
US4303786A (en) Isonitrile derivatives of macromolecules containing hydroxyl groups
CN116023525B (en) 2-position (1, 4-disubstituted-1, 2, 3-triazole) modified chitosan derivative and preparation method and application thereof
IT9021315A1 (en) IMPROVED PROCEDURE FOR THE PREPARATION OF CEPHALOSPORINE
US4675391A (en) Glycoside derivatives
CN117625572B (en) Method for preparing immobilized galactose oxidase and application thereof
JPH093088A (en) Production of aminodisaccharide and chitin or its analogue polysaccharides
NO115737B (en)
EP0216162A2 (en) A method of preparing indoles or indole derivatives, coupled via position 4, 5, 6, or 7, the indoles or indole derivatives concerned, as well as the use thereof
CN116284493A (en) 2-position imidazolinone modified chitosan derivative and preparation method and application thereof
KR810000048B1 (en) Process for preparing cephalexin by immobilized enzyme
US4513145A (en) 2-Methylchromone derivatives and process for their preparation
SU644760A1 (en) Method of obtaining immobilized enzymes
SU1102811A1 (en) Process for preparing amino derivatives of 1,2-dihydro-3h-1,4-benzdiazepin-2-ones
US3620920A (en) Process for the manufacture of physiologically active compounds
JPS5889189A (en) Antibiotic a and b and their preparations
JPS6371196A (en) Production of d-n-carbamyl-alpha-amino acid
JPS60164484A (en) Novel hydrolase and preparation thereof
CN114478467A (en) Fluorocyclohexanone spiro 1, 3-dioxane chiral derivative and preparation method and application thereof
CN117946367A (en) Preparation method of water-based polyurethane leather coating containing natural antibacterial factors
JP2511677B2 (en) Method for producing N-carboxymethoxymethylene carbonyl chitosan compound
EP0137601B1 (en) Enzymatic synthesis of gallic acid esters

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination